BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19369455)

  • 1. The CPPDD-associated ANKH M48T mutation interrupts the interaction of ANKH with the sodium/phosphate cotransporter PiT-1.
    Wang J; Tsui HW; Beier F; Tsui FW
    J Rheumatol; 2009 Jun; 36(6):1265-72. PubMed ID: 19369455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of sporadic chondrocalcinosis with a -4-basepair G-to-A transition in the 5'-untranslated region of ANKH that promotes enhanced expression of ANKH protein and excess generation of extracellular inorganic pyrophosphate.
    Zhang Y; Johnson K; Russell RG; Wordsworth BP; Carr AJ; Terkeltaub RA; Brown MA
    Arthritis Rheum; 2005 Apr; 52(4):1110-7. PubMed ID: 15818664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microcytosis in ank/ank mice and the role of ANKH in promoting erythroid differentiation.
    Wang J; Wang C; Tsui HW; Las Heras F; Cheng EY; Iscove NN; Chiu B; Inman RD; Pritzker KP; Tsui FW
    Exp Cell Res; 2007 Dec; 313(20):4120-9. PubMed ID: 17950726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the amino terminus of ANKH in two US families with calcium pyrophosphate dihydrate crystal deposition disease.
    Williams CJ; Pendleton A; Bonavita G; Reginato AJ; Hughes AE; Peariso S; Doherty M; McCarty DJ; Ryan LM
    Arthritis Rheum; 2003 Sep; 48(9):2627-31. PubMed ID: 13130483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in intracellular localisation of ANKH mutants that relate to mechanisms of calcium pyrophosphate deposition disease and craniometaphyseal dysplasia.
    Vijen S; Hawes C; Runions J; Russell RGG; Wordsworth BP; Carr AJ; Pink RC; Zhang Y
    Sci Rep; 2020 May; 10(1):7408. PubMed ID: 32366894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P5L mutation in Ank results in an increase in extracellular inorganic pyrophosphate during proliferation and nonmineralizing hypertrophy in stably transduced ATDC5 cells.
    Zaka R; Stokes D; Dion AS; Kusnierz A; Han F; Williams CJ
    Arthritis Res Ther; 2006; 8(6):R164. PubMed ID: 17067391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH.
    Williams CJ; Zhang Y; Timms A; Bonavita G; Caeiro F; Broxholme J; Cuthbertson J; Jones Y; Marchegiani R; Reginato A; Russell RG; Wordsworth BP; Carr AJ; Brown MA
    Am J Hum Genet; 2002 Oct; 71(4):985-91. PubMed ID: 12297989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial calcium pyrophosphate dihydrate deposition disease and the ANKH gene.
    Williams CJ
    Curr Opin Rheumatol; 2003 May; 15(3):326-31. PubMed ID: 12707589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of ANKH in pathologic mineralization of cartilage.
    Williams CJ
    Curr Opin Rheumatol; 2016 Mar; 28(2):145-51. PubMed ID: 26599446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of articular chondrocalcinosis--role of ANKH.
    Abhishek A; Doherty M
    Nat Rev Rheumatol; 2011 Feb; 7(2):96-104. PubMed ID: 21102543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ANKH ΔE490Mutation in Calcium Pyrophosphate Dihydrate Crystal Deposition Disease (CPPDD) affects tissue non-specific Alkaline Phosphatase (TNAP) activities.
    Wang J; Tsui HW; Beier F; Pritzker KP; Inman RD; Tsui FW
    Open Rheumatol J; 2008; 2():23-30. PubMed ID: 19088867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of ANK in Calcium Pyrophosphate Deposition Disease.
    Mitton-Fitzgerald E; Gohr CM; Bettendorf B; Rosenthal AK
    Curr Rheumatol Rep; 2016 May; 18(5):25. PubMed ID: 27032788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autosomal dominant early childhood seizures associated with chondrocalcinosis and a mutation in the ANKH Gene.
    McKee S; Pendleton A; Dixey J; Doherty M; Hughes A
    Epilepsia; 2004 Oct; 45(10):1258-60. PubMed ID: 15461680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of chondrocalcinosis.
    Zaka R; Williams CJ
    Osteoarthritis Cartilage; 2005 Sep; 13(9):745-50. PubMed ID: 15951203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ANKH gene and familial calcium pyrophosphate dihydrate deposition disease.
    Netter P; Bardin T; Bianchi A; Richette P; Loeuille D
    Joint Bone Spine; 2004 Sep; 71(5):365-8. PubMed ID: 15474385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and genetic analysis of ANK in arthritis and bone disease.
    Gurley KA; Reimer RJ; Kingsley DM
    Am J Hum Genet; 2006 Dec; 79(6):1017-29. PubMed ID: 17186460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the role of ANKH in ankylosing spondylitis.
    Timms AE; Zhang Y; Bradbury L; Wordsworth BP; Brown MA
    Arthritis Rheum; 2003 Oct; 48(10):2898-902. PubMed ID: 14558096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease.
    Richette P; Bardin T; Doherty M
    Rheumatology (Oxford); 2009 Jul; 48(7):711-5. PubMed ID: 19398486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcium pyrophosphate dihydrate-crystal induced arthropathy].
    Schneider Internist-Rheumatologe Chefarzt Der Abteilung Für Rheumatologie P; Schneider I
    Z Rheumatol; 2004 Feb; 63(1):10-21. PubMed ID: 14991274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the progressive ankylosis gene in cartilage mineralization.
    Zaka R; Williams CJ
    Curr Opin Rheumatol; 2006 Mar; 18(2):181-6. PubMed ID: 16462526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.